10/14 · WedPicks
Latest picks
监管与产业动态精选评分6565 中文产业新闻精选Chinese source评分8989 康方依沃西一线晚期肺癌头对头 K 药 总生存期 30.8 个月对 22.6 个月
JAMA精选评分6767 Cold and Room-Temperature Platelets in Cardiac Surgery
JAMA精选评分6161 Tucidinostat Plus R-CHOP for Large B-Cell Lymphoma
JAMA精选评分5252 Error in Results
中文产业新闻精选Chinese source评分7272 BioNTech BNT113联合帕博利珠单抗AHEAD-MERIT 2/3期首批顶线未达PFS主要终点
BioSpace精选评分5050 Syndax ends fibrosis program for Niktimvo after mid-stage disappointment
BioSpace精选评分8787 AbbVie, Genmab's Epkinly sets ‘new standard of care’ in first-line lymphoma in Phase 3
最新进展10月13日 18:52EPCORE DLBCL-2 III期:艾可瑞妥单抗+R-CHOP显著改善初治DLBCL PFS
STAT News精选评分5656 STAT+: Concerns grow on safety issues tied to Neurocrine Biosciences rare disease drug
中文产业新闻精选Chinese source评分7373 翰森制药HS-10380治疗急性精神分裂症2b期达到主要终点
medRxiv Oncology精选评分4141 FORESEE: A prospective feasibility trial of functional precision oncology for metastatic breast cancer patients
BioPharma Dive精选评分5353 First Tracks climbs on ‘impressive’ celiac study data
临床试验登记精选评分3535 Study of ORJ-001 for the Treatment of IPF
临床试验登记精选评分3535 Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine (NAL) Extended-Release (ER) Tablets
监管与产业动态精选评分3737 Comparative efficacy of topical garlic extract and 20% podophyllin solution in the treatment of female genital warts: a triple-blind randomized clinical trial
BioPharma Dive精选评分5757 Bristol Myers trial revisions shake confidence in new class of fibrosis drugs
最新进展10月12日 23:21BMS阿达米帕兰IPF三期60mg达标、120mg未达显著
中文产业新闻精选Chinese source评分7373 百时美施贵宝 RYZ101 三期 ACTION-1 治疗 GEP-NETs 达 PFS 主要终点
BioSpace精选评分6969 RevMed's Rasonque gets a subtype data asterisk, but analysts remain bullish
中文产业新闻精选Chinese source评分6767 mRNA肿瘤疫苗三期读出阳性,拐点上的三个变量
中文产业新闻精选Chinese source评分6060 阿斯利康ALXN1850低磷酸酯酶症三期临床失败